<乌鸦传媒>Lower BP Might Mean Less Cardiac Conduction Disease SPRINT post hoc analysis suggests a means for prevention May 03, 2023
<乌鸦传媒>The Worst Redo Option After TAVR? Choose the first procedure wisely, because repeats have mortality implications, researchers say Apr 24, 2023
<乌鸦传媒>Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
<乌鸦传媒>ECMO Therapy Out of Reach for Multiple Socioeconomic Groups Sex, insurance status, and income all factors in access to advanced critical care therapy Apr 07, 2023
<乌鸦传媒>Timing of Pacemaker, ICD Infections Suggests Closer Wound Checks for Some Researchers stress early detection and treatment of CIED infection Apr 05, 2023
<乌鸦传媒>More Sophisticated Imaging Doesn't Necessarily Mean Better Outcomes in Ischemic HF But cardiac MRI, PET may still have value in some patients, per AIMI-HF trial Mar 09, 2023
<乌鸦传媒>Virtual Care Team Optimized Heart Failure Medications During Hospitalization Trial shows modest effect with daily recommendations to the treating team Mar 07, 2023
<乌鸦传媒>Minimally Invasive Mitral Valve Surgery Earns Confidence in Expert Hands Decision for mini thoracotomy may rest on patient preference, expert operator availability Mar 06, 2023
<乌鸦传媒>Hunt for Hibernating Myocardium Doesn't Help PCI for Ischemic Cardiomyopathy REVIVED-BCIS2 challenges long-held beliefs about myocardial viability Mar 05, 2023
<乌鸦传媒>Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients." Mar 04, 2023
<乌鸦传媒>Women Still Face Higher Risks for Mortality After CABG Sex disparities in adverse outcomes, including death, didn't change in the last decade Mar 01, 2023
<乌鸦传媒>Omecamtiv Mecarbil for Heart Failure Turned Down by FDA End of the road for cardiac myosin activator Mar 01, 2023
<乌鸦传媒>Arrival of TEER Has Helped Surgeons' Track Records Nationwide analysis of technology's effect since FDA approval 10 years ago Feb 06, 2023
<乌鸦传媒>Fixing Heart Failure Workforce Issues: Baby Steps Start This Year Pay, curriculum changes proposed to attract more doctors Jan 05, 2023
<乌鸦传媒>The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs Treatment no longer limited by ejection fraction Dec 27, 2022
<乌鸦传媒>TAVR at 20: How Much Longer Will Medicare Mandate a Registry? Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
<乌鸦传媒>Heart Failure From Meth Use: Growing Beast Lurks in the Shadows Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
<乌鸦传媒>Early Cardiac Amyloidosis Still Bad News Without Treatment Observational study supports treating even asymptomatic patients Nov 16, 2022
<乌鸦传媒>Upfront ECMO Disappoints for Cardiogenic Shock High-cost procedure not yet justified as an early strategy Nov 07, 2022
<乌鸦传媒>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
<乌鸦传媒>Experts Agree Intravenous Iron Shows Promise for Heart Failure Patients While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
<乌鸦传媒>Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the ED Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
<乌鸦传媒>Definitive Answer on Steroids for Infant Heart Surgery Falls Short STRESS trial misses primary endpoint but secondary benefits are suggestive Nov 06, 2022
<乌鸦传媒>Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysis Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
<乌鸦传媒>Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalization Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
<乌鸦传媒>Empagliflozin Protects At-Risk Patients From CKD Progression Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
<乌鸦传媒>Heart Failure Common in Cystic Fibrosis Patients Other frequent cardiac comorbidities included Afib and acute MI, real-world analysis shows Oct 18, 2022
<乌鸦传媒>Despite Exciting Newcomer Drugs, Uptake of HF Meds Still Meek Across Oceans U.S. not alone in slow initiation, low target-dose achievement, and early discontinuation Oct 14, 2022
<乌鸦传媒>Lower Entresto Doses Suffice in the Real World Reassuring findings for patients who don't tolerate the maximum ARNI dose Oct 10, 2022
<乌鸦传媒>FDA Approves At-Home Furosemide for Heart Failure Strong diuretic to become available outside the hospital setting Oct 10, 2022
<乌鸦传媒>Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmed Small randomized trial challenges conventional thinking about sodium Oct 05, 2022
<乌鸦传媒>Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons Heart pump placement plus anticoagulation suffice for patients, even those with Afib Oct 05, 2022
<乌鸦传媒>The Search Is On for Another Xeno Heart Transplant Recipient Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
<乌鸦传媒>Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data Analyses continue to support wider adoption of dapagliflozin, researchers say Oct 03, 2022
<乌鸦传媒>UNOS to Revamp Heart Allocation Rules to Rein in Transplant Waitlist Tricks It may be goodbye to priority tiers, hello to points-based ranking system in coming years Oct 03, 2022
<乌鸦传媒>Growing Calls to Marry HF Specialists With Cardiac Critical Care Cardiac ICU staffing issues require a multidisciplinary team approach, some say Oct 02, 2022
<乌鸦传媒>MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
<乌鸦传媒>Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
<乌鸦传媒>Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
<乌鸦传媒>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
